Detail akcie SDS Optic Br online

Business Summary: SDS Optic SA is a Poland-based company engaged primarily in medical research. The Company’s primary research activity relates to the oncology sector. The Firm wishes to develop a method for early breast cancer diagnosis. The current method of diagnosis relies on biopsy and histopathology. The purpose of the tests is to identify cancer markers. The Company tries to implement InProbe method, which is faster and more accurate- the method should be able to provide results within 20 minutes. The Company is also engaged in research regarding different kinds of diseases such as fungal diseases. The Company cooperates with specialists from different fields such as biology, medicine, technology, and sciences related to medicine.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Sds Optic SA revenues increased from PLN0K to PLN2.1M. Net loss decreased 63% to PLN2.7M. Revenues reflect Sale of Goods and Materials increase from PLN0K to PLN1.8M, Sales of Products increase from PLN0K to PLN256K. Lower net loss reflects Other Costs by type decrease of 78% to PLN122K (expense), External Expenses decrease of 14% to PLN2.2M (expense).